Literature DB >> 27482954

Patterns and Consequences of Multimorbidity in the General Population: There is No Chronic Disease Management Without Rheumatic Disease Management.

Daniela Simões1, Fábio A Araújo2, Milton Severo2, Teresa Monjardino2, Ivo Cruz3, Loreto Carmona4, Raquel Lucas2.   

Abstract

OBJECTIVE: To identify empirical model-based patterns of multimorbidity from chronic noncommunicable diseases in the general population, with a focus on the contribution of rheumatic and musculoskeletal diseases (RMDs), and to quantify their association with adverse health outcomes.
METHODS: Cross-sectional data from the Portuguese Fourth National Health Survey were analyzed (n = 23,754). Latent class analysis was used to identify patterns of coexistence of 11 chronic noncommunicable diseases (RMDs, diabetes mellitus, hypertension, chronic obstructive pulmonary disease, stroke, depression, myocardial infarction, cancer, osteoporosis, asthma, and renal failure). Based on the Outcome Measures in Rheumatology, filter 2.0, health outcomes included life impact, pathophysiologic manifestations, and resource use. We assessed the association between patterns and adverse health outcomes, through sex-, age-, and body mass index-adjusted prevalence ratios with 95% confidence intervals, obtained using Poisson regression.
RESULTS: Four patterns of chronic noncommunicable diseases co-occurrence were identified and labeled as low disease probability, cardiometabolic conditions, respiratory conditions, and RMDs and depression. RMDs were highly prevalent in patients with chronic diseases (from 38.6% in cardiometabolic conditions to 66.7% in RMDs and depression). While negative self-rated health, short-term disability, and chronic pain were more strongly associated with cardiometabolic conditions and respiratory conditions, all multimorbidity patterns were similarly associated with long-term disability, frequent health care utilization, and out-of-pocket health care expenses.
CONCLUSION: Our study emphasizes RMDs as a major presence in multimorbidity in the general population. All multimorbidity patterns were associated with a wide set of adverse health outcomes. Management strategies for the patient with chronic cardiometabolic, respiratory, or depressive conditions should also target RMDs.
© 2016, American College of Rheumatology.

Entities:  

Mesh:

Year:  2016        PMID: 27482954     DOI: 10.1002/acr.22996

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  8 in total

1.  Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study.

Authors:  Hai-Long Wang; Yong-Ming Zhou; Guang-Zhao Zhu; Zhu Yang; Bao-Jin Hua
Journal:  Clin Rheumatol       Date:  2017-05-16       Impact factor: 2.980

2.  The population impact of rheumatic and musculoskeletal diseases in relation to other non-communicable disorders: comparing two estimation approaches.

Authors:  Daniela Simões; Fábio Azevedo Araújo; Teresa Monjardino; Milton Severo; Ivo Cruz; Loreto Carmona; Raquel Lucas
Journal:  Rheumatol Int       Date:  2018-02-08       Impact factor: 2.631

3.  Do replicable profiles of multimorbidity exist? Systematic review and synthesis.

Authors:  Ljoudmila Busija; Karen Lim; Cassandra Szoeke; Kerrie M Sanders; Marita P McCabe
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

4.  The association between daily physical exercise and pain among women with fibromyalgia: the moderating role of pain catastrophizing.

Authors:  Asimina Lazaridou; Myrella Paschali; Kristin Schreiber; Laura Galenkamp; Michael Berry; Theodoros Paschalis; Vitaly Napadow; Robert R Edwards
Journal:  Pain Rep       Date:  2020-07-27

5.  Exercise combined with Acceptance and Commitment Therapy (ExACT) compared to a supervised exercise programme for adults with chronic pain: study protocol for a randomised controlled trial.

Authors:  Máire-Bríd Casey; Keith Smart; Ricardo Segurado; Conor Hearty; Hari Gopal; Damien Lowry; Dearbhail Flanagan; Lance McCracken; Catherine Doody
Journal:  Trials       Date:  2018-03-22       Impact factor: 2.279

6.  Use of latent class analysis to identify multimorbidity patterns and associated factors in Korean adults aged 50 years and older.

Authors:  Bomi Park; Hye Ah Lee; Hyesook Park
Journal:  PLoS One       Date:  2019-11-13       Impact factor: 3.240

7.  A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial.

Authors:  Jeffrey R Curtis; Christopher Herrem; 'Matladi N Ndlovu; Cathy O'Brien; Yusuf Yazici
Journal:  Arthritis Res Ther       Date:  2017-09-29       Impact factor: 5.156

8.  Examining the relationship between rheumatoid arthritis, multimorbidity and adverse health-related outcomes: A systematic review protocol.

Authors:  Jordan Canning; Stefan Siebert; Bhautesh D Jani; Frances S Mair; Barbara I Nicholl
Journal:  J Comorb       Date:  2020-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.